Bavarian Nordic A/S (BVNRY)
7.45
+0.24
(+3.33%)
USD |
OTCM |
May 03, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.742B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -13.87% |
| Valuation | |
| PE Ratio | 7.928 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.659 |
| Price to Book Value | 1.135 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0016 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 75.59% |
Profile
| Bavarian Nordic A/S is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif. |
| URL | https://www.bavarian-nordic.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | May. 08, 2024 |
| Last Earnings Release | Nov. 16, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 27, 2020 |
Ratings
Profile
| Bavarian Nordic A/S is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif. |
| URL | https://www.bavarian-nordic.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | May. 08, 2024 |
| Last Earnings Release | Nov. 16, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 27, 2020 |